This single-center prospective cohort study of women undergoing germline genetic testing serves as an important reminder to consider CDH1 mutations in women younger than 45 presenting with invasive lobular carcinoma of the breast, particularly with a family history, as this may be the first sign of dreaded hereditary diffuse gastric cancer. | Corso, JAMA Netw Open 2024
